Harnessing the Disease Signatures From Endometrium and Menstrual Blood to Identify Avenues for the Treatment of Chronic Conditions Such as Endometriosis and Related Pathologies: This is an Observational Study Aimed at Shedding Light on Women's Health

Launched by CYCLE THERAPEUTICS LTD · May 23, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on improving understanding and treatment options for various women's health conditions, including endometriosis, infertility, and endometrial cancer. Researchers will collect samples from menstrual fluid and biopsies from women to identify patterns in diseases. By analyzing this information, the study aims to find new ways to diagnose and treat these conditions, ultimately leading to better health outcomes for women.

Women aged 16 and older who are currently menstruating or undergoing tissue removal procedures are encouraged to participate. Even women without any symptoms are welcome, as their samples will help researchers understand what a healthy state looks like. Participants can expect to provide samples easily—like pouring menstrual fluid into a tube—and will receive health insights after each donation. The study, which will last four years, is being conducted by Cycle Therapeutics, a company dedicated to curing endometriosis. Your involvement could contribute to significant advancements in women’s health!

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Menstruating
• Exclusion Criteria:
• • Not menstruating